A detailed history of May Hill Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, May Hill Capital, LLC holds 1,369 shares of LLY stock, worth $1.4 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,369
Previous 1,261 8.56%
Holding current value
$1.4 Million
Previous $983 Million 6.26%
% of portfolio
0.31%
Previous 0.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$625.65 - $812.69 $67,570 - $87,770
108 Added 8.56%
1,369 $1.04 Billion
Q2 2025

Aug 01, 2025

SELL
$713.71 - $898.95 $229,100 - $288,562
-321 Reduced 20.29%
1,261 $983 Million
Q1 2025

Apr 30, 2025

BUY
$725.72 - $929.72 $15,240 - $19,524
21 Added 1.35%
1,582 $1.31 Billion
Q4 2024

Feb 12, 2025

BUY
$727.2 - $932.06 $1.14 Million - $1.45 Million
1,561 New
1,561 $1.21 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track May Hill Capital, LLC Portfolio

Follow May Hill Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of May Hill Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on May Hill Capital, LLC with notifications on news.